Reducing Harm Associated with Anticoagulation: Practical Considerations of Argatroban Therapy in Heparin-Induced Thrombocytopenia

Author： Hursting Marcie J.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.32, Iss.3, 2009-01, pp. : 203-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Argatroban Anticoagulation for Heparin-Induced Thrombocytopenia in Elderly Patients

By Bartholomew John R.  

Drugs & Aging, Vol. 24, Iss. 6, 2007-01 ,pp. : 489-499

Adis International

Access to resources Recommend Favorite

Argatroban use in heparin-induced thrombocytopenia

By Boggio Lisa N   Oza Veeral M  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 11, 2008-08 ,pp. : 1963-1967

Informa Healthcare

Access to resources Recommend Favorite

Argatroban/heparin: Heparin-induced thrombocytopenia and coagulation disorders: case report

By  

Reactions Weekly, Vol. 1, Iss. 1214, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Argatroban: A Review of its Use in the Management of Heparin-Induced Thrombocytopenia

By Dhillon Sohita  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 4, 2009-08 ,pp. : 261-282

Adis International

Access to resources Recommend Favorite

Anticoagulation in Patients with Heparin-Induced Thrombocytopenia undergoing Percutaneous Coronary Angiography and Interventions

By  

Current Pharmaceutical Design, Vol. 14, Iss. 12, 2008-04 ,pp. : 1176-1185

Bentham Science Publishers

Access to resources Recommend Favorite